Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Randomized Controlled Trial to Assess Efficacy and Safety of Rituximab in Patients With Acute Rheumatic Fever in Africa

NCT05682196 is registered in ClinicalTrials.gov with African Academy of Methodology and Statistics as lead sponsor.

NCT NCT05682196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05682196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Randomized Controlled Trial to Assess Efficacy and Safety of Rituximab in Patients With Acute Rheumatic Fever in Africa
Lead sponsor
African Academy of Methodology and Statistics
Phase
Phase 2
Overall status
Suspended
Start date
January 5, 2023
Completion date
February 1, 2025
Enrollment
234 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatic heart disease in children